Analysis on the causes for refractory GERD

Abstract

To analyze the causes of failure in conventional treatment to refractory gastroesophageal reflux diseases (GERD) patients, 16 refractory GERD patients (group R) and 16 cases of GERD primarily diagnosed (group P) were studied. Endoscopy, pathologic examination and¹⁴C urea breath test were conducted in every patient. 24 h ambulatory pH and bilirubin monitoring were performed with Digitrapper MK III and Synetics Bilitec 2000. It was found that esophagitis in group R was more severe than in group P. The rate of Helicobacter pylori infection in group R was significantly lower than in group P. Fraction time pH below 4.00 was not longer while the bile reflux represented by fraction time abs above 0.14 was greater for patients in the group R as compared with those in the group P. The mixed refluxes and pure bile refluxes between the two groups had significant difference. The reflux episodes in the group R mainly occurred during nights. These results indicated that severe esophagitis, especially Barrett's esophagus with complications makes it difficult to control GERD. Severe duodenogastroesophageal refluxes (DGER) are often accompanied by refractory GERD. Mixed refluxes aggravate the esophageal injuries. Pure bile refluxes and nocturnal refluxes may cause failure of administration of proton pump inhibitors (PPI) in the morning. Helicobacter pylori infection and acid refluxes may not be the direct cause of refractoriness. Individual refractory GERD patient without abnormal results on pH or bile reflux recently should be diagnosed again.

Keywords

GERD / refractory / cause

References

[1] BarrettM W, MyersJ C, WatsonD I, et al. . Dietary interference with the use of Bilitec to assessble reflux. Dis Esophagus, 1999, 12(1): 60-60

[2] HatlebakkJ G, KatzP O, CastellD O. Medical therapy—management of the refractory patient. Gastroenterol Clin North America, 1999, 28(4): 847-847

[3] KatzP O, SilmanJ, KatzkaD, et al. . H pylori infection increases nocturnal acid control on proton pump inhibitors [abstr]. Am J Gastroenterol, 1998, 93: 1641-1641

[4] NehraD, HowellP, WilliamsC P, et al. . Toxic bile acids in gastro-esophageal reflux disease: Influence of gastric acidity. Gut, 1999, 44: 598-598

[5] KatzP O, AndersonC, KhouryR, et al. . Gastroesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors. Aliment Pharmacal Ther, 1998, 12: 1231-1231